Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

MOGHISSI KAMRAN S. MD FACOG; BOYCE, CHARLES R. MD, FACOG
Obstetrics & Gynecology: March 1976
Article: PDF Only
Buy

Efficacy of oral medroxyprogesterone acetate (MPA) was assessed in 35 women with an established diagnosis of endometriosis (33 pelvic and 2 abdominal). MPA was given in a dosage of 30 mg dally for 90 days. Results indicated improvement or remission in all cases, even though breakthrough bleeding occurred in 8. Twenty-six were treated for associated infertility. Twelve of these became pregnant following treatment. Pregnancy rate in those women whose husbands were fertile was 90%. Side effects included spotting and breakthrough bleeding. The patients usually remained amenorrhecic and anovulatory while receiving MPA. Posttreatment resumption of ovulation was prompt. The findings indicate that oral MPA is a useful therapeutic agent in the management of minimal to moderate endometriosis, particularly when it is associated with infertility.

© 1976 The American College of Obstetricians and Gynecologists